Molecular imaging to track Parkinson's disease and atypical parkinsonisms: New imaging frontiers

Survival and dementia inGBA-associated Parkinson's disease: The mutation matters

(2016) Roberto Cilia et al.   ANNALS OF NEUROLOGY

The prominent role of serotonergic degeneration in apathy, anxiety and depression inde novoParkinson’s disease

(2016) Audrey Maillet et al.   BRAIN

Fatigue in Parkinson's disease: The contribution of cerebral metabolic changes

(2016) Sang Soo Cho et al.   HUMAN BRAIN MAPPING

Cerebral glucose metabolism and cognition in newly diagnosed Parkinson's disease: ICICLE-PD study

(2016) M J Firbank et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Biomarkers for dementia and mild cognitive impairment in Parkinson's disease

(2016) Manuel Delgado-Alvarado et al.   MOVEMENT DISORDERS

Elevated in vivo [18F]-AV-1451 uptake in a patient with progressive supranuclear palsy

(2016) Jochen Hammes et al.   MOVEMENT DISORDERS

Serotonin-to-dopamine transporter ratios in Parkinson disease

(2016) Andreas-Antonios Roussakis et al.   NEUROLOGY

Influence of microglial activation on neuronal function in Alzheimer's and Parkinson's disease dementia

(2015) Zhen Fan et al.   Alzheimers & Dementia

Loss of phosphodiesterase 10A expression is associated with progression and severity in Parkinson’s disease

(2015) Flavia Niccolini et al.   BRAIN

Classification of Parkinsonian Syndromes from FDG-PET Brain Data Using Decision Trees with SSM/PCA Features

(2015) D. Mudali et al.   Computational and Mathematical Methods in Medicine

Dopaminergic correlates of metabolic network activity in Parkinson's disease

(2015) Florian Holtbernd et al.   HUMAN BRAIN MAPPING

Single versus multiple impulse control disorders in Parkinson’s disease: an 11C-raclopride positron emission tomography study of reward cue-evoked striatal dopamine release

(2015) Kit Wu et al.   JOURNAL OF NEUROLOGY

Metabolic Topology of Neurodegenerative Disorders: Influence of Cognitive and Motor Deficits

(2015) O. Granert et al.   JOURNAL OF NUCLEAR MEDICINE

Automated Differential Diagnosis of Early Parkinsonism Using Metabolic Brain Networks: A Validation Study

(2015) M. Tripathi et al.   JOURNAL OF NUCLEAR MEDICINE

Apathy in Parkinson's disease: clinical features, neural substrates, diagnosis, and treatment

(2015) Javier Pagonabarraga et al.   LANCET NEUROLOGY

In-vivo imaging of grey and white matter neuroinflammation in Alzheimer’s disease: a positron emission tomography study with a novel radioligand, [18F]-FEPPA

(2015) I Suridjan et al.   MOLECULAR PSYCHIATRY

Reproducibility of a Parkinsonism-related metabolic brain network in non-human primates: A descriptive pilot study with FDG PET

(2015) Yilong Ma et al.   MOVEMENT DISORDERS

Striatal and Cortical β-Amyloidopathy and Cognition in Parkinson's Disease

(2015) Neha Shah et al.   MOVEMENT DISORDERS

The Influence of Bilateral Subthalamic Nucleus Deep Brain Stimulation on Impulsivity and Prepulse Inhibition in Parkinson's Disease Patients

(2015) Lucy Gee et al.   STEREOTACTIC AND FUNCTIONAL NEUROSURGERY

Frequency of Cholinergic and Caudate Nucleus Dopaminergic Deficits Across the Predemented Cognitive Spectrum of Parkinson Disease and Evidence of Interaction Effects

(2015) Nicolaas I. Bohnen et al.   JAMA Neurology

Neuroimaging Analysis of the Dopamine Basis for Apathetic Behaviors in an MPTP-Lesioned Primate Model

(2015) LinLin Tian et al.   PLoS One

Imaging Striatal Microglial Activation in Patients with Parkinson’s Disease

(2015) Yuko Koshimori et al.   PLoS One

Salience network and parahippocampal dopamine dysfunction in memory-impaired Parkinson disease

(2014) Leigh Christopher et al.   ANNALS OF NEUROLOGY

Imaging acetylcholinesterase density in peripheral organs in Parkinson's disease with 11C-donepezil PET

(2014) Trine Gjerløff et al.   BRAIN

Grey matter hypometabolism and atrophy in Parkinson’s disease with cognitive impairment: a two-step process

(2014) Rafael González-Redondo et al.   BRAIN

A disease-specific metabolic brain network associated with corticobasal degeneration

(2014) Martin Niethammer et al.   BRAIN

Consistent abnormalities in metabolic network activity in idiopathic rapid eye movement sleep behaviour disorder

(2014) Ping Wu et al.   BRAIN

Network modulation following sham surgery in Parkinson’s disease

(2014) Ji Hyun Ko et al.   JOURNAL OF CLINICAL INVESTIGATION

Serotonergic mechanisms responsible for levodopa-induced dyskinesias in Parkinson’s disease patients

(2014) Marios Politis et al.   JOURNAL OF CLINICAL INVESTIGATION

Impulse control behaviours in patients with Parkinson's disease after subthalamic deep brain stimulation: de novo cases and 3-year follow-up

(2014) P Amami et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

The phenotypic spectrum of progressive supranuclear palsy: A retrospective multicenter study of 100 definite cases

(2014) Gesine Respondek et al.   MOVEMENT DISORDERS

Differentiation of Progressive Supranuclear Palsy: clinical, imaging and laboratory tools

(2013) R. M. Liscic et al.   ACTA NEUROLOGICA SCANDINAVICA

[18F]T807, a novel tau positron emission tomography imaging agent for Alzheimer's disease

(2013) Chun-Fang Xia et al.   Alzheimers & Dementia

Validation of midbrain positron emission tomography measures for nigrostriatal neurons in macaques

(2013) Christopher A. Brown et al.   ANNALS OF NEUROLOGY

Combined insular and striatal dopamine dysfunction are associated with executive deficits in Parkinson’s disease with mild cognitive impairment

(2013) Leigh Christopher et al.   BRAIN

Disease duration and the integrity of the nigrostriatal system in Parkinson’s disease

(2013) Jeffrey H. Kordower et al.   BRAIN

Affective disorders in Parkinsonʼs disease

(2013) Kelly S.G. Aminian et al.   CURRENT OPINION IN NEUROLOGY

A concise radiosynthesis of the tau radiopharmaceutical, [18F]T807

(2013) Timothy M. Shoup et al.   JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS

Principal component analysis of PiB distribution in Parkinson and Alzheimer diseases

(2013) M. C. Campbell et al.   NEUROLOGY

Imaging of Tau Pathology in a Tauopathy Mouse Model and in Alzheimer Patients Compared to Normal Controls

(2013) Masahiro Maruyama et al.   NEURON

Dopaminergic Neuronal Imaging in Genetic Parkinson's Disease: Insights into Pathogenesis

(2013) Alisdair McNeill et al.   PLoS One

The Nature of Progression in Parkinson’s Disease: An Application of Non-Linear, Multivariate, Longitudinal Random Effects Modelling

(2013) Lisa Kuramoto et al.   PLoS One

Bilateral stimulation of the subthalamic nucleus has differential effects on reactive and proactive inhibition and conflict-induced slowing in Parkinson’s disease

(2013) Ignacio Obeso et al.   EXPERIMENTAL BRAIN RESEARCH

Multiclass classification of FDG PET scans for the distinction between Parkinson's disease and atypical parkinsonian syndromes

(2013) Gaëtan Garraux et al.   NeuroImage-Clinical

Metabolic brain networks in translational neurology: Concepts and applications

(2012) Martin Niethammer et al.   ANNALS OF NEUROLOGY

Validation of nigrostriatal positron emission tomography measures: Critical limits

(2012) Morvarid Karimi et al.   ANNALS OF NEUROLOGY

Pathologic Accumulation of α-Synuclein and Aβ in Parkinson Disease Patients With Dementia

(2012) Paul T. Kotzbauer et al.   ARCHIVES OF NEUROLOGY

Dopamine pathway loss in nucleus accumbens and ventral tegmental area predicts apathetic behavior in MPTP-lesioned monkeys

(2012) C.A. Brown et al.   EXPERIMENTAL NEUROLOGY

Low nigrostriatal reserve for motor parkinsonism in nonhuman primates

(2012) Samer D. Tabbal et al.   EXPERIMENTAL NEUROLOGY

Clinical features of dopamine agonist withdrawal syndrome in a movement disorders clinic

(2012) Margarita Pondal et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Subregional Patterns of Preferential Striatal Dopamine Transporter Loss Differ in Parkinson Disease, Progressive Supranuclear Palsy, and Multiple-System Atrophy

(2012) M. Oh et al.   JOURNAL OF NUCLEAR MEDICINE

Increased medial orbitofrontal [18F]fluorodopa uptake in Parkinsonian impulse control disorders

(2012) Juho Joutsa et al.   MOVEMENT DISORDERS

The nigrostriatal system in the presymptomatic and symptomatic stages in the MPTP monkey model: A PET, histological and biochemical study

(2012) J. Blesa et al.   NEUROBIOLOGY OF DISEASE

Extrastriatal dopaminergic abnormalities of DA homeostasis in Parkinson's patients with medication-induced pathological gambling: A [11C] FLB-457 and PET study

(2012) Nicola J. Ray et al.   NEUROBIOLOGY OF DISEASE

Cognitive Impairment in Parkinson’s Disease: The Dual Syndrome Hypothesis

(2012) Angie A. Kehagia et al.   Neurodegenerative Diseases

A -amyloid deposition in patients with Parkinson disease at risk for development of dementia

(2012) M. Petrou et al.   NEUROLOGY

No Differential Regulation of Dopamine Transporter (DAT) and Vesicular Monoamine Transporter 2 (VMAT2) Binding in a Primate Model of Parkinson Disease

(2012) LinLin Tian et al.   PLoS One

Serotonin Neuron Loss and Nonmotor Symptoms Continue in Parkinson's Patients Treated with Dopamine Grafts

(2012) M. Politis et al.   Science Translational Medicine

Clinicopathological correlations in corticobasal degeneration

(2011) Suzee E. Lee et al.   ANNALS OF NEUROLOGY

Cue-induced striatal dopamine release in Parkinson's disease-associated impulsive-compulsive behaviours

(2011) S. S. O'Sullivan et al.   BRAIN

Abnormal Metabolic Brain Networks in a Nonhuman Primate Model of Parkinsonism

(2011) Yilong Ma et al.   JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

Cerebral Glucose Metabolic Features of Parkinson Disease and Incident Dementia: Longitudinal Study

(2011) N. I. Bohnen et al.   JOURNAL OF NUCLEAR MEDICINE

Role of serotonergic 1A receptor dysfunction in depression associated with Parkinson's disease

(2011) Benedicte Ballanger et al.   MOVEMENT DISORDERS

Graft-induced dyskinesias in Parkinson's disease: High striatal serotonin/dopamine transporter ratio

(2011) Marios Politis et al.   MOVEMENT DISORDERS

Network correlates of the cognitive response to levodopa in Parkinson disease

(2011) P. J. Mattis et al.   NEUROLOGY

Dopamine Transporter SPECT Imaging in Corticobasal Syndrome

(2011) Roberto Cilia et al.   PLoS One

Age-specific progression of nigrostriatal dysfunction in Parkinson's disease

(2010) Raúl de la Fuente-Fernández et al.   ANNALS OF NEUROLOGY

Impulse Control Disorders in Parkinson Disease

(2010) Daniel Weintraub et al.   ARCHIVES OF NEUROLOGY

Non-motor dopamine withdrawal syndrome after surgery for Parkinson's disease: predictors and underlying mesolimbic denervation

(2010) S. Thobois et al.   BRAIN

Fatigue in Parkinson's disease is linked to striatal and limbic serotonergic dysfunction

(2010) N. Pavese et al.   BRAIN

Two Binding Sites for [3H]PBR28 in Human Brain: Implications for TSPO PET Imaging of Neuroinflammation

(2010) David R Owen et al.   JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

Differential diagnosis of parkinsonism: a metabolic imaging study using pattern analysis

(2010) Chris C Tang et al.   LANCET NEUROLOGY

Amyloid imaging of Lewy body-associated disorders

(2010) Erin R. Foster et al.   MOVEMENT DISORDERS

Dopamine turnover increases in asymptomatic LRRK2 mutations carriers

(2010) Vesna Sossi et al.   MOVEMENT DISORDERS

Reduced dopamine transporter density in the ventral striatum of patients with Parkinson's disease and pathological gambling

(2010) Roberto Cilia et al.   NEUROBIOLOGY OF DISEASE

Progression of dopaminergic depletion in a model of MPTP-induced Parkinsonism in non-human primates. An 18F-DOPA and 11C-DTBZ PET study

(2010) Javier Blesa et al.   NEUROBIOLOGY OF DISEASE

Staging of serotonergic dysfunction in Parkinson's Disease: An in vivo 11C-DASB PET study

(2010) Marios Politis et al.   NEUROBIOLOGY OF DISEASE

Neurotransmitter changes in dementia with Lewy bodies and Parkinson disease dementia in vivo

(2010) J. C. Klein et al.   NEUROLOGY

Depressive symptoms in PD correlate with higher 5-HTT binding in raphe and limbic structures

(2010) M. Politis et al.   NEUROLOGY

Drug-induced deactivation of inhibitory networks predicts pathological gambling in PD

(2010) T. van Eimeren et al.   NEUROLOGY

Higher dopamine transporter density in Parkinson’s disease patients with depression

(2010) Andre C. Felicio et al.   PSYCHOPHARMACOLOGY

Serotonergic Neurons Mediate Dyskinesia Side Effects in Parkinson's Patients with Neural Transplants

(2010) M. Politis et al.   Science Translational Medicine

Stimulation of the subthalamic nucleus and impulsivity: Release your horses

(2009) Benedicte Ballanger et al.   ANNALS OF NEUROLOGY

Increased striatal dopamine release in Parkinsonian patients with pathological gambling: a [11C] raclopride PET study

(2009) T. D. L. Steeves et al.   BRAIN

Longitudinal progression of sporadic Parkinson's disease: a multi-tracer positron emission tomography study

(2009) R. Nandhagopal et al.   BRAIN

Dopamine dysregulation syndrome, impulse control disorders and punding after deep brain stimulation surgery for Parkinson’s disease

(2009) Shen-Yang Lim et al.   JOURNAL OF CLINICAL NEUROSCIENCE

A Multitracer Dopaminergic PET Study of Young-Onset Parkinsonian Patients With and Without Parkin Gene Mutations

(2009) M.-J. Ribeiro et al.   JOURNAL OF NUCLEAR MEDICINE

Nigrostriatal dysfunction in homozygous and heterozygousparkingene carriers: An18F-dopa PET progression study

(2009) Nicola Pavese et al.   MOVEMENT DISORDERS

Neuroinflammation in the living brain of Parkinson's disease

(2009) Yasuomi Ouchi et al.   PARKINSONISM & RELATED DISORDERS

[11C]-PK11195 PET: Quantification of neuroinflammation and a monitor of anti-inflammatory treatment in Parkinson's disease?

(2009) A.L. Bartels et al.   PARKINSONISM & RELATED DISORDERS

Abnormal metabolic networks in atypical parkinsonism

(2008) Thomas Eckert et al.   MOVEMENT DISORDERS